BioAge Labs (BIOA) Total Non-Current Liabilities (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Total Non-Current Liabilities data on file, last reported at $18.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 40.95% year-over-year to $18.1 million; the trailing twelve-month figure through Mar 2026 stood at $18.1 million (down 40.95% YoY), and the FY2025 full-year result was $22.5 million, down 35.72% from the prior year.
• Total Non-Current Liabilities slipped to $18.1 million in Q1 2026, from $22.5 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $66.4 million in Q4 2023 to a low of $18.1 million in Q1 2026.
• A 4-year average of $31.3 million and a median of $27.4 million in 2025 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities slumped 47.34% in 2024 and advanced 19.36% in 2025, its largest moves.
• Tracing BIOA's Total Non-Current Liabilities over 4 years: stood at $66.4 million in 2023, then tumbled by 47.34% to $35.0 million in 2024, then sank by 35.72% to $22.5 million in 2025, then dropped by 19.64% to $18.1 million in 2026.
• Business Quant data shows BIOA's Total Non-Current Liabilities at $18.1 million in Q1 2026, $22.5 million in Q4 2025, and $27.5 million in Q3 2025.